Maria Angeles Lopez-Olivo Selected Research

Maria Angeles Lopez-Olivo Research Topics

9	Rheumatoid Arthritis 10/2017 - 10/2009
2	Neoplasms (Cancer) 01/2023 - 10/2017
1	COVID-19 01/2023
1	Pain (Aches) 01/2023
1	Arthralgia (Joint Pain) 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Exanthema (Rash) 01/2023
1	Fatigue 01/2023
1	Systemic Scleroderma (Systemic Sclerosis) 01/2022
1	Disease Progression 01/2015
1	Necrosis 05/2013
1	Infections 05/2013
1	Gout 11/2012

4	Antirheumatic Agents (DMARD)IBA 10/2017 - 10/2009
2	Rituximab (Mabthera)FDA Link 01/2015 - 11/2009
2	Methotrexate (Mexate)FDA LinkGeneric 01/2015 - 06/2014
2	Etanercept (Enbrel)FDA Link 05/2013 - 11/2009
2	tocilizumab (atlizumab)FDA Link 01/2011 - 07/2010
1	Immune Checkpoint InhibitorsIBA 01/2023
1	COVID-19 VaccinesIBA 01/2023
1	Inactivated VaccinesIBA 01/2023
1	VaccinesIBA 01/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	ametantrone (HAQ)IBA 10/2017
1	amsonic acid (DAS)IBA 10/2017
1	tofacitinibIBA 10/2017
1	Febuxostat FDA Link 11/2012
1	Allopurinol (Remid)FDA LinkGeneric 11/2012
1	Uric Acid (Urate)IBA 11/2012
1	Interleukin-6 (Interleukin 6)IBA 07/2010
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 11/2009
1	Abatacept (Orencia)FDA Link 11/2009
1	Infliximab (Remicade)FDA Link 11/2009
1	Adalimumab (Humira)FDA Link 11/2009

1	Drug Therapy (Chemotherapy) 01/2023
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Stem Cell Transplantation 01/2022